Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinson Disease, Secondary

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Parkinson Disease, Secondary in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (90.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barthel, H; Collingridge, DR; Hermann, W; Hesse, S; Kluge, R; Sabri, O; Wagner, A1
Bartenstein, P; Lerch, H; Masur, H; Oberwittler, C; Saur, HB; Schober, O1
Dichgans, J; Jauch, M; Klockgether, T; Müller-Schauenburg, W; Petersen, D; Schulz, JB; Spieker, S; Voigt, K1
Janssen, AG; Kapucu, O; Sokole-Busemann, E; van Royen, EA; Verhoeff, NP1
Grundmann, M; Huber, G; Reiche, W1
Booij, J; Tissingh, G; van Royen, EA; Winogrodzka, A; Wolters, EC1
Abi-Dargham, A; Baldwin, RM; Bowers, MB; Charney, DS; D'Souza, CD; Fingado, CL; Innis, RB; Jatlow, P; Kanes, SJ; Laruelle, M; Seibyl, JP; Zoghbi, SS1
Heinz, A; Knable, MB; Raedler, T; Weinberger, DR1
Bettin, S; Dietrich, J; Kämpfer, I; Knapp, WH; Lössner, J; Reuter, M; Schäfer, A; Seese, A; Wagner, A1
Egan, MF; Knable, MB; Lafargue, T; Pickar, D; Raedler, TJ; Urbina, RA; Weinberger, DR1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinson Disease, Secondary

ArticleYear
IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism.
    Journal of neural transmission. Supplementum, 1997, Volume: 50

    Topics: Benzamides; Brain; Cocaine; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Humans; Iodine Radioisotopes; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Risk Factors; Tomography, Emission-Computed, Single-Photon

1997

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinson Disease, Secondary

ArticleYear
[Comparison of D2 receptor scintigraphy (123I-IBZM) with cerebral perfusion (99m-Tc-HMPAO) in extrapyramidal disorders].
    Nuklearmedizin. Nuclear medicine, 1994, Volume: 33, Issue:5

    Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Benzamides; Brain; Cerebellum; Cerebrovascular Circulation; Dopamine Antagonists; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Middle Aged; Organotechnetium Compounds; Oximes; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1994

Other Studies

8 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Parkinson Disease, Secondary

ArticleYear
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:2

    Topics: Adult; Benzamides; Brain Mapping; Cerebellum; Cocaine; Corpus Striatum; Dopamine; Female; Hepatolenticular Degeneration; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Psychometrics; Pyrrolidines; Reference Values; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon

2003
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:9

    Topics: Adult; Aged; Benzamides; Brain; Cerebellar Ataxia; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine; Tomography, Emission-Computed, Single-Photon

1994
Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:12

    Topics: Adolescent; Adult; Aged; Benzamides; Cerebellum; Contrast Media; Corpus Striatum; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Models, Structural; Observer Variation; Occipital Lobe; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1993
[Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
    Der Radiologe, 1995, Volume: 35, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Benzamides; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1995
Imaging D2 receptor occupancy by endogenous dopamine in humans.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1997, Volume: 17, Issue:3

    Topics: Adult; Affect; alpha-Methyltyrosine; Animals; Benzamides; Brain; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Humans; Iodine Radioisotopes; Male; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase

1997
Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
    Psychiatry research, 1997, Sep-29, Volume: 75, Issue:2

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Brain; Brain Mapping; Dopamine Antagonists; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Tomography, Emission-Computed, Single-Photon

1997
[Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:5

    Topics: Adult; Aged; Basal Ganglia; Benzamides; Carrier Proteins; Cerebellum; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Frontal Lobe; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed

1997
In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine.
    Psychiatry research, 1999, Apr-26, Volume: 90, Issue:2

    Topics: Adult; Benzamides; Benzodiazepines; Case-Control Studies; Contrast Media; Corpus Striatum; Dose-Response Relationship, Drug; Female; Humans; Male; Olanzapine; Parkinson Disease, Secondary; Pirenzepine; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon

1999